Form 4: LifeStance Health Group CEO Reports Tax Withholding Transaction
SEC Form 4 Filing
CEO David Bourdon reports transaction related to tax withholding obligations upon vesting of RSUs.
Summary
- On March 10, 2025, David Bourdon, CEO of LifeStance Health Group, had 10,884 common stock shares withheld by the issuer to satisfy tax withholding obligations.
- This was in connection with the net settlement of Restricted Stock Units (RSUs) that vested on that date.
- The shares were withheld at a price of $7.11.
- Following the transaction, Bourdon directly owns 888,239 shares of LifeStance Health Group common stock.
Sentiment
Score: 7
Explanation: The document is a routine SEC filing related to tax obligations, indicating standard compensation practices. It doesn't suggest any significant positive or negative sentiment.
Management Comments
- The shares withheld represent a reduction of shares issued to the Reporting Person upon settlement of vested RSUs and do not constitute any open-market sale.
Key Dates
| Date | Description |
|---|---|
| 03/10/2025 | Date of transaction: Shares withheld for tax obligations related to RSU vesting. |
| 05/19/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, LifeStance Health Group, LFST, David Bourdon, CEO, RSU, Tax Withholding, Beneficial Ownership, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.